Request Demo
Last update 14 Jul 2025
BC008-1A
Last update 14 Jul 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms BC008-1A |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors), TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with BC008-1ANCT06773481
A Phase I Clinical Study to Evaluate the Safety and Preliminary Efficacy of BC008-1A Injection in Subjects With Recurrent CNS WHO Grade 4 Glioma.
NCT06773507
An Open-label, Multicenter, Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics and Preliminary Efficacy of BC008-1A Injection in Subjects With Advanced Solid Tumors
ChiCTR2300069226
An open-label, multicenter, phase I clinical study to evaluate the safety, tolerability and PK characteristics and initial efficacy of BC008-1A injection in subjects with advanced solid tumors
100 Clinical Results associated with BC008-1A
Login to view more data
100 Translational Medicine associated with BC008-1A
Login to view more data
100 Patents (Medical) associated with BC008-1A
Login to view more data
100 Deals associated with BC008-1A
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 12 May 2025 | |
| Metastatic Esophageal Squamous Cell Carcinoma | Phase 1 | China | 12 May 2025 | |
| Glioblastoma Multiforme | Phase 1 | China | 07 Apr 2025 | |
| High grade glioma | Phase 1 | China | 07 Apr 2025 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 11 Apr 2023 | |
| Solid tumor | Phase 1 | - | 15 Sep 2022 | |
| Glioblastoma | IND Approval | China | 08 Jul 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free